companydata.dkGXP PHARMAID ApS: Financial statements 2022
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 349,682 and a net result of DKK -324,771 compared with DKK -503,961 the year before. That is a decrease of 3.8% compared with the year before. Equity amounted to DKK 366,516. The solvency ratio was 29.4%. The company had 1 employee in the financial year.
- Gross Profit
- 349,682 kr.
- Profit/Loss
- -324,771 kr.
- Equity
- 366,516 kr.
- Total Assets
- 1,246,435 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 350 t. | -325 t. | 367 t. | 1 |
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
Events in 2022
GXP PHARMAID ApS has published its annual report for 2021. Gross profit came to DKK 363,324, and the net result was DKK -503,961.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.